These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 975646)

  • 1. Diphosphonate treatment of Paget's disease.
    Finerman GA; Gonick HC; Smith RK; Mayfield JM
    Clin Orthop Relat Res; 1976 Oct; (120):115-24. PubMed ID: 975646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diphosphonate therapy of paget's disease of bone.
    Canfield R; Rosner W; Skinner J; McWhorter J; Resnick L; Feldman F; Kammerman S; Ryan K; Kunigonis M; Bohne W
    J Clin Endocrinol Metab; 1977 Jan; 44(1):96-106. PubMed ID: 401827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term experience using EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of Paget's disease].
    Sieghart S
    Wien Med Wochenschr; 1986 Nov; 136(21-22):583-5. PubMed ID: 3103338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of polyosseous Paget disease].
    Kovarik J; Niebauer B; Woloszczuk W; Frühwald F; Kolbe H
    Wien Klin Wochenschr; 1985 Mar; 97(7):311-5. PubMed ID: 3922124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Paget's disease of bone with ethane-1, hydroxy-1,1 diphosphonate (EHDP) at a low dosage (5 mg/kg/day).
    Alexandre CM; Chapuy MC; Vignon E; Edouard C; Johnston CC; Meunier PJ
    Clin Orthop Relat Res; 1983 Apr; (174):193-205. PubMed ID: 6403270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A single infusion of Pamidronate (APD) in Paget's disease of bone].
    Thiébaud D; Jaeger P; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1989 Jan; 119(3):71-4. PubMed ID: 2711157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of disodium dichloromethylene diphosphonate on Paget's disease of bone.
    Meunier PJ; Chapuy MC; Alexandre C; Bressot C; Edouard C; Vignon C; Mathieu L; Trechsel U
    Lancet; 1979 Sep; 2(8141):489-92. PubMed ID: 90215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminohexane diphosphonate in the treatment of Paget's disease of bone.
    Atkins RM; Yates AJ; Gray RE; Urwin GH; Hamdy NA; Beneton MN; Rosini S; Kanis JA
    J Bone Miner Res; 1987 Aug; 2(4):273-9. PubMed ID: 3455614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Paget's disease of bone.
    Evans RA
    Med J Aust; 1983 Feb; 1(4):159-62. PubMed ID: 6405139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of Paget's bone disease with sodium ethidronate.
    Fromm GA; Schajowicz F; Casco C; Ghiringhelli G; Mautalen CA
    Am J Med Sci; 1979; 277(1):29-37. PubMed ID: 106728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term therapy of Paget's disease of bone with EHDP.
    Siris ES; Canfield RE; Jacobs TP; Baquiran DC
    Arthritis Rheum; 1980 Oct; 23(10):1177-84. PubMed ID: 6775644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
    Alexandre C; Chapuy MC; Bressot C; Vignon E; Arlot M; Mathieu L; Edouard C; Johnston CC; Meunier PJ
    Nouv Presse Med; 1980 Nov; 9(45):3429-33. PubMed ID: 6777752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained biochemical effects of short treatment of Paget's disease of bone with dichloromethylene diphosphonate.
    Chapuy MC; Charhon SA; Meunier PJ
    Metab Bone Dis Relat Res; 1983; 4(6):325-8. PubMed ID: 6229683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and clinical responses to dichloromethylene diphosphonate (Cl2MDP) in Paget's disease of bone.
    Douglas DL; Duckworth T; Kanis JA; Preston C; Beard DJ; Smith TW; Underwood I; Woodhead JS; Russell RG
    Arthritis Rheum; 1980 Oct; 23(10):1185-92. PubMed ID: 6448604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic fracture due to severe osteomalacia following low-dose diphosphonate treatment of Paget's disease of bone.
    Evans RA; Dunstan CR; Hills E; Wong SY
    Aust N Z J Med; 1983 Jun; 13(3):277-9. PubMed ID: 6416243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Paget's bone disease with a bisphosphonate.
    Fromm GA; Plantalech L; Casco C; González D; Mautalen CA
    Medicina (B Aires); 1984; 44(3):245-51. PubMed ID: 6545558
    [No Abstract]   [Full Text] [Related]  

  • 17. [Paget's disease of the skeleton].
    Ziegler R
    Orthopade; 1988 Sep; 17(5):407-10. PubMed ID: 3054712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term effects of dichloromethylene diphosphonate in Paget's disease of bone.
    Delmas PD; Chapuy MC; Vignon E; Charhon S; Briancon D; Alexandre C; Edouard C; Meunier PJ
    J Clin Endocrinol Metab; 1982 Apr; 54(4):837-44. PubMed ID: 6460781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined treatment of Paget's disease of bone with calcitonin and the diphosphonate EHDP].
    Jaeger P; Bischoff-Delaloye A; Burckhardt P
    Schweiz Med Wochenschr; 1981 Dec; 111(49):1893-7. PubMed ID: 6800028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent effect of zoledronic acid in Paget's disease.
    Tziomalos K; Florentin M; Krikis N; Perifanis V; Karagiannis A; Harsoulis F
    Clin Exp Rheumatol; 2007; 25(3):464-6. PubMed ID: 17631747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.